A MULTIPROFESSIONAL APPROACH
TO COLLABORATIVE CARE
September 12 -13 , 2026
orlando, fl
Hilton orlando
Summit Agenda
Pending 10.50 Category I CME/CEU
Schedule and Faculty subject to change.
Saturday, September 12, 2026
7:45 -9:15 AM
BREAKFAST
7:45 AM – 8:00 AM
Welcome Address and Collaborative Care Summit Mission
Presented by: Risha Bellomo, Executive Director of CCS
8:00 AM – 8:30 AM
Beyond Dry Skin: Sjögren’s and the Mucocutaneous Spectrum
Presented by: Rheumatology and Dermatology
Sjögren’s is a complex autoimmune disease that extends beyond dryness, with significant mucocutaneous and systemic involvement. This session will highlight key dermatologic, oral, and ocular manifestations, along with diagnostic challenges and evolving treatment approaches. Faculty will emphasize the importance of collaboration between dermatology and rheumatology to improve recognition, coordination of care, and patient outcomes.
8:30 AM – 9:15 AM
PRODUCT THEATER
9:15 AM – 9:50 AM
Breaking the Silos: Collaborative Care in Complex Autoimmune Disease of AD & Psoriasis
Presented by: Dermatology, Rheumatology, and Allergy/Immunology
Atopic dermatitis and psoriasis are no longer viewed as isolated skin conditions, but as systemic inflammatory diseases with significant comorbidities. This session will explore shared immune pathways, overlapping disease states, and the expanding role of targeted therapies across specialties.
Through a collaborative, case-based approach, faculty will discuss treatment selection, coordination of care, and how dermatology, rheumatology, and allergy/immunology can work together to optimize outcomes in complex patients.
9:50 AM – 10:30 AM
Rare but Not Invisible: Evolving Therapeutics in Complex Immune-Mediated Disease
Presented by: Dermatology, Rheumatology, GI, and Allergy/Immunology
This session will highlight rare and complex immune-mediated diseases that require multidisciplinary care, including dermatomyositis, pyoderma gangrenosum, mast cell disorders, and epidermolysis bullosa. Faculty will explore diagnostic challenges, systemic involvement, and emerging targeted therapies, emphasizing the importance of coordinated care across specialties.
10:30 AM – 11:00 AM
PRODUCT THEATER
11:00 AM – 11:30 AM
BREAK WITH EXHIBITORS
11:30 AM – 12:00 PM
Biologic Advances in Urticaria and Angioedema: A Multispecialty Approach
Presented by: Dermatology and Allergy/Immunology
Chronic urticaria and angioedema are complex conditions that often require individualized, multidisciplinary care. In this case-based session, faculty from dermatology and allergy/immunology will walk through real-world patient scenarios, highlighting diagnostic challenges and treatment decisions in refractory disease.
Through interactive discussion, attendees will explore how to select and sequence biologic therapies, manage patients with overlapping conditions, and collaborate across specialties to improve outcomes and quality of life.
12:00 PM – 12:45 PM
Interdisciplinary Case Clinics
Presented by: CCS Attendees
In this highly interactive session, selected attendees will present real-world patient cases, highlighting complex diagnostic and management challenges. Each case will be opened for discussion with multidisciplinary faculty and audience participants, encouraging diverse perspectives and shared problem-solving.
This collaborative format emphasizes practical decision-making, cross-specialty coordination, and real-time insights that can be applied directly to clinical practice.
12:45 PM – 1:45 PM
LUNCH
1:00 PM – 1:45 PM
MEDICAL SYMPOSIUM
1:45 PM – 2:30 PM
Hormones in Action: PCOS, Androgen Excess, Acne, and Hair Loss
Presented by: Gynecology, Dermatology, and Endocrinology
Hormonal dysregulation plays a key role in common dermatologic conditions such as acne, hirsutism, and hair loss. This session will focus on PCOS and androgen-driven disease, using case-based discussion to highlight diagnostic approaches, metabolic considerations, and treatment strategies.
Faculty will explore how dermatology, gynecology, and endocrinology can collaborate to manage these patients more effectively, with an emphasis on long-term outcomes and quality of life.
2:30 PM – 3:00 PM
Perimenopause Beyond the Hot Flash: Hair, Skin, and Mood
Presented by: Dermatology and Gynecology
Perimenopause is a complex transitional phase that affects far more than vasomotor symptoms, with significant impact on skin, hair, mood, weight, and bone health. In this case-based session, faculty will explore how hormonal fluctuations contribute to changes in body composition, bone density, and dermatologic health.
Through real-world patient scenarios, attendees will gain practical insights into both hormonal and non-hormonal treatment strategies, emphasizing a collaborative approach to improving overall health and quality of life during this transition.
3:00 PM – 3:30 PM
PRODUCT THEATER
3:30 PM – 4:00 PM
BREAK WITH EXHIBITORS
4:00 PM – 4:30 PM
Hormones and Longevity: The Role of Estrogen and Testosterone in Whole-Patient Care
Presented by: Dermatology , Gynecology, and Endocrinology
Estrogen and testosterone play critical roles far beyond skin health, influencing bone density, muscle mass, metabolic function, sexual health, and overall aging. In this case-based session, faculty will explore how hormonal changes impact the body systemically, including effects on skin integrity, body composition, and long-term health.
Through real-world patient scenarios, attendees will gain practical insights into evaluating hormonal influence, understanding risks and benefits of therapy, and incorporating hormone-based strategies into collaborative, patient-centered care.
4:30 PM – 5:00 PM
Peptides in Practice: Emerging Therapies, Evidence, and Clinical Considerations
Presented by:
Peptides are gaining increasing attention across dermatology, hormone health, and longevity medicine, yet their role in clinical practice continues to evolve. This session will provide an overview of peptide biology, mechanisms of action, and current evidence supporting their use.
Faculty will review potential applications in skin health, metabolic function, and aging, while also addressing safety, regulatory considerations, and the distinction between evidence-based therapies and emerging trends. Attendees will leave with a clearer understanding of where peptides may fit into clinical practice today—and where the field is heading.
5:30 PM – 7:30 PM
NETWORKING RECEPTION for Attendees, Faculty, and Sponsors
Sunday, October 19, 2025
7:45 – 9:15 AM
BREAKFAST
8:00 AM – 8:30 AM
What’s in the Patient’s Toolkit? Understanding Prior Treatments and Avoiding Therapeutic Redundancy
Presented by: Dermatology, Allergy/Immunology, Primary Care
By the time patients present to specialty care, many have already cycled through a wide range of over-the-counter products, prescriptions, and alternative therapies. This session will explore the concept of the “patient toolkit,” focusing on how prior treatments influence current management decisions.
Faculty will discuss strategies for identifying what patients have already used, avoiding therapeutic redundancy, and optimizing treatment plans. Emphasis will be placed on improving communication across care settings and selecting therapies that build on—rather than repeat—previous interventions.
8:30 AM – 9:15 AM
PRODUCT THEATER
9:15 AM – 9:45 AM
Polypharmacy and the Skin: Drug Eruptions, Interactions, and Adherence
Presented by: Dermatology, Pharmacist, and Primary Care
Patients with complex disease states are often treated with multiple medications, increasing the risk of drug eruptions, interactions, and adherence challenges. This session will explore common and high-risk dermatologic reactions, strategies for identifying culprit medications, and approaches to optimizing adherence.
Faculty will highlight the critical role of pharmacists and collaborative care teams in improving medication safety and patient outcomes.
9:45 AM – 10:10 AM
Advanced Topical Therapies and Vehicle Optimization: Enhancing Efficacy Across Specialties
Presented by: Dermatology, Allergy/Immunology, Primary Care
Advanced topical therapies are rapidly transforming the management of inflammatory skin diseases, offering targeted, non-systemic options across specialties. This session will explore novel mechanisms of action, including non-steroidal and targeted agents, and how formulation and vehicle selection impact efficacy, tolerability, and adherence.
Faculty will discuss how these therapies are being used across dermatology, allergy/immunology, and primary care, with practical strategies for tailoring treatment based on disease type, body location, and patient preference.
10:10 AM – 10:30 AM
Breaking the Cycle: Steroid-Sparing Strategies in Dermatologic Care
Presented by:
Many patients cycle through repeated courses of topical corticosteroids without achieving long-term disease control, leading to frustration, overuse, and potential adverse effects. This session will focus on strategies to move beyond the “steroid cycle” by incorporating steroid-sparing therapies and long-term management approaches.
Faculty will discuss when to transition away from steroids, how to introduce advanced topical and systemic options, and how to align treatment plans across specialties to improve outcomes and adherence.
10:30 AM – 11:00 AM
PRODUCT THEATER
11:00 AM – 11:30 AM
BREAK WITH EXHIBITORS
11:30 AM – 12:00 PM
Hidradenitis Suppurativa: A Systemic Disease Beyond the Skin
Presented by: Dermatology and Endocrinology
Hidradenitis suppurativa (HS) is a chronic, inflammatory disease with significant systemic, metabolic, and psychosocial implications. Through representative patient cases, this session will explore the underlying pathophysiology, comorbidities, and disease burden associated with HS, emphasizing that it extends far beyond the skin.
Faculty will highlight early recognition, common delays in diagnosis, and the importance of multidisciplinary evaluation in improving patient outcomes and quality of life.
12:00 PM – 12:30 PM
Advancing HS Care: Therapeutic Strategies and Multidisciplinary Management
Presented by: Dermatology, Surgery, and Endocrinology
This case-based session will focus on the real-world management of hidradenitis suppurativa, using patient scenarios to guide therapeutic decision-making across disease severity and clinical presentation.
Faculty will explore treatment selection, including biologics, procedural interventions, and combination approaches, while highlighting how dermatology, surgery, and primary care collaborate to optimize outcomes and long-term disease control.
12:30 PM – 1:30 PM
LUNCH
12:45 PM – 1:30 PM
PRODUCT THEATER
1:30 PM – 1:50 PM
Microbiome in Motion: The Gut-Skin Axis and Systemic Inflammation
Presented by: Dermatology and Gastroenterology
The gut–skin axis plays a critical role in systemic inflammation and dermatologic disease. This session will explore the underlying mechanisms connecting the microbiome to skin health, including immune modulation, barrier function, and inflammatory signaling pathways.
Faculty will discuss how emerging research in the microbiome is shaping our understanding of disease and influencing future therapeutic approaches across specialties.
1:50 PM – 2:20 PM
Inflammation Across Systems: GI Disease, Skin Manifestations, and Shared Therapeutics
Presented by: Dermatology and Gastroenterology
Gastrointestinal diseases often present with cutaneous findings that can serve as early indicators of systemic inflammation. Using representative patient cases to anchor discussion, this session will explore dermatologic manifestations of conditions such as inflammatory bowel disease, celiac disease, and other GI disorders.
Faculty will highlight shared inflammatory pathways and review therapeutic strategies—including biologics and targeted therapies—used across specialties, emphasizing coordinated, multidisciplinary care.
2:20 PM – 2:45 PM
Probiotics, Prebiotics, and the Microbiome: Clinical Application vs. Hype
Presented by: Dermatology and Gastroenterology
As interest in microbiome-directed therapies grows, clinicians are increasingly asked about the role of probiotics, prebiotics, and dietary interventions in skin and systemic health. This session will distinguish evidence-based approaches from emerging trends.
Faculty will provide practical guidance on patient counseling, product selection, and how these interventions may be incorporated into clinical care.
2:45 PM – 3:15 PM
PRODUCT THEATER
3:15 PM – 3:40 PM
Oncodermatology Essentials: Skin Care and Systemic Therapy Fundamentals in Cancer Patients
Presented by: Dermatology and Oncology
Cancer therapies significantly alter skin biology and require a different approach to daily skin care and management. This session will provide a practical overview of how chemotherapy, targeted therapies, and immunotherapy impact the skin.
Faculty will review foundational skin care strategies, common early dermatologic changes, and what patients experience throughout treatment, preparing attendees to better recognize and manage skin-related complications in cancer care.
3:40 PM – 4:15 PM
The Skin as a Window: Cutaneous Clues to Underlying Malignancy
Presented by: Dermatology and Oncology
The skin can serve as an early indicator of internal malignancy, offering important diagnostic clues that may precede systemic symptoms. This session will highlight key cutaneous findings associated with underlying cancers, including paraneoplastic syndromes and other high-yield clinical presentations.
Faculty will focus on recognizing patterns that warrant further evaluation, emphasizing the role of dermatology in early detection and multidisciplinary cancer care.
4:15 PM – 4:45 PM
When It’s Not Just a Rash: Managing Cutaneous Toxicities in Cancer Therapy
Presented by: Dermatology and Oncology
Cutaneous toxicities are among the most common complications of cancer therapy and can significantly impact treatment adherence and patient quality of life. Using real-world patient scenarios, this session will explore the evaluation and management of skin reactions associated with chemotherapy, targeted therapies, and combination regimens.
Faculty will discuss practical strategies to manage adverse events while maintaining effective cancer treatment, highlighting the importance of coordinated care across specialties.
4:45 PM – 5:15 PM
Join us as we close the Collaborative Care Summit with final reflections, key takeaways, and a look ahead at the future of multidisciplinary care. We will recognize our faculty, partners, and attendees who made this experience possible.
Stay for raffle drawings and a chance to connect one last time before departure.
Featured Faculty
- Risha Bellomo, Executive Director
- Tracee Blackburn, PA-C
- Jennifer Seminerio, MD
- Paola Gonzalez, MPAS, PA-C
- Drew Kuraitis, MD, PhD
- Ahuva Cices, MD